Reactive oxygen species (ROS) are oxygen-containing molecular entities which are more potent and effective oxidizing agents than is molecular oxygen itself. With the exception of phagocytic cells, where ROS play an important physiological role in defense reactions, ROS have classically been considered undesirable byproducts of cell metabolism, existing several cellular mechanisms aimed to dispose them. Recently, however, ROS have been considered important intracellular signaling molecules, which may act as mediators or second messengers in many cell functions. This is the proposed role for ROS in oxygen sensing in systems, such as carotid body chemoreceptor cells, pulmonary artery smooth muscle cells, and erythropoietin-producing cells. These unique cells comprise essential parts of homeostatic loops directed to maintain oxygen levels in multicellular organisms in situations of hypoxia. The present article examines the possible significance of ROS in these three cell systems, and proposes a set of criteria that ROS should satisfy for their consideration as mediators in hypoxic transduction cascades. In none of the three cell types do ROS satisfy these criteria, and thus it appears that alternative mechanisms are responsible for the transduction cascades linking hypoxia to the release of neurotransmitters in chemoreceptor cells, contraction in pulmonary artery smooth muscle cells and erythropoietin secretion in erythropoietin producing cells.
Cell systems with sensitivity to physiological hypoxia
The appearance of O 2 on a previously anaerobic earth, forced living organisms to develop antioxidant defense systems. Organisms that evolved tolerance to O 2 also developed mechanisms to use this new element for metabolic transformations and efficient energy production by using electron transport chains with O 2 as the final electron acceptor. The development of efficient and secure energy production systems allowed the appearance of multicellular organisms. The acquisition of O 2 and nutrients by diffusion from the surrounding aqueous medium was succeeded in multicellular organisms by the appearance of a circulatory system, a system of tubes to carry and to distribute O 2 and nutrients among all cells of the living organism. Evolution later provided an oxygenating or respiratory system capable of supplying O 2 to the fluid moving in the circulatory system, and the moving fluid itself evolved to blood to gain in capacity to transport O 2 . All these acquisitions provided living organisms with the independence necessary to abandon water and to move freely on land. Nevertheless, full acquisition of terrestrial freedom was only possible by the simultaneous appearance of homeostatic mechanisms. Some of those homeostatic mechanisms match O 2 supply to whole-body energetic needs, by monitoring O 2 levels in the body, and altering the overall function of the respiratory and circulatory systems, as well as the capacity of blood to transport O 2 .
There are two main systems regarding O 2 homeostasis. They conform two functional loops with their origin in the O 2 -monitoring cells, the chemoreceptor cells of the carotid body (CB) and the erythropoietin (EPO)-producing cells (Richalet, 1997; Gonzalez, 1998) . These two cell types are receptor -effector units, which detect arterial blood O 2 levels and respond with a secretory response. The functional loop originated in the CB works as follows: Chemoreceptors cells detect arterial blood P O 2 and become activated when arterial P O 2 decreases; they release neurotransmitters which activate the sensory nerve endings of the carotid sinus nerve, whose central projections end in the nucleus of the tractus solitarius in the medulla. Integration of the carotid sinus nerve input in the respiratory control centers of the brain stem results in an increased activity of the respiratory muscles, with increased ventilation and increased alveolar and arterial blood P O 2 (Gonzalez et al., , 1994 . EPO-producing cells, which in adult animals are mainly located in the kidney, also detect arterial blood O 2 levels and are activated by hypoxia to release EPO; this glycoproteic hormone reaches the bone marrow and activates erythropoiesis. An increase in the red blood cell mass and ultimately in the capacity of the blood to transport O 2 follow (Jelkmann, 1992) . These two systems probably are aided in maintaining the homeostasis of O 2 by the pulmonary artery smooth muscle cells (PASMC), which, as the other cell two types, monitor oxygen levels and react to hypoxia with a contractile response leading to vasoconstriction and lung blood flow redistribution which would ameliorate the oxygenation of blood (Marshall et al., 1994) . We have previously defined physiological hypoxia and these three cell types as endowed with sensitivity to physiological hypoxia (Gonzalez, 1998) .
These three cell systems, contributing to the homeostasis of O 2 , share other properties. They have a very low threshold to hypoxia, becoming activated at an arterial P O 2 of :70 mmHg and increasing their effector activity with the intensity of hypoxia. In contrast, the response to hypoxia in most cells is a decrease in their activity (Hochachka et al., 1997) and as the hypoxic threshold for this behavior is higher, a more intense hypoxia is needed to elicit it. The different behavior of the cell types involved in homeostatic loops versus general cells of the organism allows to predict that the detection of O 2 levels (i.e. (O 2 -sensing), if linked to O 2 -consumption rate, should be associated to an increase of O 2 -consumption in the case of the cells involved in homeostatic loops and to a decrease in the rest of the cells. The increase in O 2 -consumption during hypoxia in the former cells is an absolute requirement to support the increased activity they exhibit in these circumstances; the decrease in O 2 -consumption during hypoxia in the rest of the cells is inferred from the near shutdown of all energy-requiring processes. Alternatively, O 2 -sensing could be independent of O 2 -consumption rate in both categories of cells. Whatever the case, there are experimental observations supporting the contention that the cell types involved in homeostatic loops, as exemplified by the CB chemoreceptor cells, exhibit an increased metabolic rate and O 2 -consumption during hypoxia. Thus, ATP levels are not significantly different in normoxia and moderate hypoxia (Verna et al., 1990) , and at the same time, hypoxia of comparable intensity in- creases glucose oxidation to CO 2 in an ouabaindependent manner (Obeso et al., 1989b (Obeso et al., , 1993 ).
An alternative way of stating the notions expressed in previous paragraphs is to say that in higher organisms there are a few cell systems devoted to maintaining O 2 levels in the entire organism which appear to have a unique mechanism for O 2 -sensing. The uniqueness of this O 2 -sensing mechanism refers to its threshold and to its ability to become coupled to and to activate cell processes demanding an energy supply. This article will consider the redox models of O 2 -sensing. We shall discuss the available information in favor and against the participation of oxygen reactive species (ROS) in O 2 -sensing and the possible significance of ROS as coupling factors between hypoxia and the effector machinery of the cells involved in the homeostasis of oxygen (Fig. 1 ).
Free radicals, oxygen reactive species (ROS) and allied molecules

Primary free radicals
Free radicals are chemically defined as atoms or molecules that have one or more unpaired electron; they usually are very reactive (Punchard and Kelly, 1996; Halliwell and Gutteridge, 1999) . The primary processes that give rise to free radicals in biological systems are divided into two main categories. Due to the high water content of living organisms, the cleavage of the chemical bonds of water by high-energy radiation (water radiolysis) constitutes an important source of free radicals according to the reaction: and methemoglobin is formed. In situations of tissue injury, especially in the processes of ischemiareperfusion, the enzyme xanthine dehydrogenase which oxidizes hypoxanthine and xanthine to uric acid using NAD + as acceptor of electrons, is modified by oxidative or proteolytic processes and converted into xanthine oxidase, which is capable of transferring the electrons of the purines to O 2 to form O 2 − . However, there is no doubt that quantitatively speaking the most important source of O 2 − is the mitochondrial electron transport chain, where univalent reduction of O 2 may take place in some steps of the overall transport system (Fig. 2) . In the two places where O 2 − can be produced (complex I and ubiquinone pool) there are electron shuttle molecules (flavin adenin mononucleotide and ubiquinone), which can accept one or two electrons. When they accept a single electron they become free radical molecules themselves capable of slipping the electron to molecular O 2 . It is estimated that a small percentage (B5%) of the total O 2 consumed by mitochondria at normal P O 2 is converted to O 2 − . To complete this overview on radicals it remains to say some words on reactive nitrogen species. Nitric oxide or nitrogen monoxide (NO ) is a free radical as it has one unpaired electron. It is a gas molecule capable of freely diffusing through cell membrane systems. NO is physiologically synthesized by a family of different nitric oxide synthases from the amino acid L-arginine. It binds to Fe 2 + of heme groups, and in fact many of its physiological actions are mediated by the soluble guanylate cyclase, which is a hemoprotein that synthesizes cGMP, although cyclase independent physiological effects have been described Bolotina et al., 1994; Ohkuma and Katsura, 2001 ). Due to its ability to react with heme groups, NO can inhibit cytochrome oxidase competitively with O 2 (Boveris et al., 2000) . In body fluids NO reacts with O 2 to give the more reactive radical nitrogen dioxide (2NO + O 2 2NO 2 ), but largely it is oxidized to nitrite ion (4NO + O 2 + 2H 2 O 4NO 2 − ) or reacts with the heme groups of oxyhemoglobin to form metahemoglobin and NO 3 − (nitrate). In fact, the evaluation of NO synthesis in vivo is quite frequently assessed by the measurement of nitrite and nitrate levels. − can be generated. The schema also shows the most commonly used inhibitors of the respiratory chain, which when acting downstream of the loci of production of O 2 − would increase, while those acting upstream will inhibit O 2 − production.
Secondary free radicals and other reacti6e species
Once generated, these three main free radicals (OH , O 2 − and NO ) can undergo an enormous variety of reactions with other molecules giving rise to new radicals or to species, which are oxidized or reduced. When new radicals are formed they are capable of undergoing further reactions originating chain reactions until one of the radicals reacts with a molecule (scavenger) to generate an unreactive compound. This widespread reactivity is the basis for the toxic effects of free radicals. For example, in their reactions with membrane lipids, OH abstract an atom of hydrogen from polyunsaturated fatty acids forming H 2 O plus a modified fatty acid which is a carbon radical species readily reacting with molecular O 2 . The incorporation of O 2 by the fatty acid carbon radical species transforms it into a peroxyl radical (R COO COOH) which in turn is capable of abstracting another hydrogen atom from a nearby polyunsaturated fatty acid, thereby spreading out the alteration of lipids; alternatively, it might attack another double bond in the same molecule to form a cyclic endoperoxide compound which finally would break to generate malonaldehyde and other byproducts whose levels are usually determined to establish the magnitude of lipid peroxidation in circumstances of interest. The final point is that the modifications and breakdown of the lipids of the membranes change their fluidity and many of their basic properties. Aditionally, peroxyl radicals, malonaldehyde and other aldehyde byproducts of lipid peroxidation, as well as OH itself and carbon centered radicals, can react with thiol and with amino groups of proteins or to attack many sites in essentially every amino acid to generate all kinds of distorted molecules (breakdown, intermolecular or intramolecular cross-linking of proteins with the formation of aggregates of membrane proteins, etc.) which ultimately imply the loss of the membrane function and its eventual destruction. The same kind of cross-linking, breakdowns and additional modifications can be made by OH in DNA molecules and between DNA and nuclear proteins leading to alterations in the repair of DNA or in its replication or transcription. In sum, OH is so reactive that it will react in the very same place where it is produced and disappear immediately as such entity, but at the same time new reactive molecules would appear which would spread the effects. The question in the context of the present article is if there exists any mechanism in the cells capable of circumscribing the action of OH for it to act as the signaling molecule during hypoxia as Kietzmann et al. (2000) suggest. Whatever the mechanism(s) it should be based in two premises: first, the production of OH should be located in a very restricted area of the cell; this restricted area must be coincident with the location of the cell machinery that initiates the hypoxic transduction cascade (for example, the O 2 -sensitive K + channels or hypoxia inducible factor 1a, HIF-1a), and second, the 'OH -receptor molecule' itself (e.g. the O 2 -sensitive K + channels or HIF-1a) should act as a very effective OH scavenger to avoid the widespread action of secondary reactive molecules with the inevitable loss of capacity to focus the hypoxic signal.
The O 2 − is considerably much less reactive than OH . It can be protonized to form HO 2 (hydroperoxyl radical) which has a greater reducing activity and which in addition is freely permeable to membranes owing to is lack of charge; both characteristics make HO 2 (Fig. 3) .
Nitric oxide (NO ) is also readily reactive with many other radicals. For example, it can react rapidly with superoxide to yield peroxynitrite (NO + O 2 − ONOO − ) and with hydroxyl radical to form nitrous acid (NO + OH HNO 2 ). Peroxynitrites and nitrous acid are nitrogen reactive species capable of reacting with SH groups of proteins and with iron/sulfur electron transporting proteins of mitochondria. As we have already mentioned, NO can react in a reversible manner with cytochrome oxidase, thereby competing with O 2 ; this might be a mechanism to control the oxidation rate of the energy-yielding compounds (nutrients). However, mitochondria must harmonize this potentially reversible regulating mechanism of NO with its ability to react with O 2 − to form peroxynitrite and through it to produce irreversible damaging effects on electron transporting proteins. Peroxynitrite can interact with tyrosine residues in a reaction catalyzed by superoxide dismutase to form the very stable 3-nitrotyroxine, changing the overall charge of the residues of tyrosine present in proteins and making it difficult for 3-nitrotyrosine containing proteins to assemble into multimeric units or to interact with other proteins (Beckman and Koppenol, 1996) and to participate in signaling cascades, by altering the efficiency of tyrosine phosphorylation. The great stability of 3-nitrotyrosine makes the measurement of its level a good index of nitric oxide/ peroxynitrite in biological systems. Peroxynitrite and other nitrogen reactive species can react with thiols, including that in glutathione, to form nitrosothiols. Special interest has recently been given to the nitrosylation of one cysteine residue in the ryanodine receptor/channel, which seems to occur in a P O 2 -dependent manner (Eu et al., 2000) . When sarcoplasmic vesicles are exposed to ambient P O 2 (: 150 mmHg) six to eight thiol residues per ryanodine receptor become oxidized, the oxidation reverting upon exposure to P O 2 of 10 mmHg, which is in the range of that physiologically encountered in the muscle; on switching back to ambient P O 2 , reoxidation of those thiol residues takes place. These cysteine residues will constitute, according to (Eu et al., 2000) , an O 2 -sensor. It is conceptually important to realize that this potential O 2 -sensor needs to be coupled to a redox system, which must be present in the sarcoplasmic reticulum vesicles, and which must be responsible for switching back and forth from the oxidized to the reduced state. Only the reduced form of the channel is susceptible for physiological modulation by NO , which does so by nitrosylating one of the reduced cysteine residues, or in other words, the redox state of the channel set by P O 2 determines the capacity to respond to (or the ability to be regulated by) NO .
ROS as mediators of the hypoxic transduction cascade
Criteria to consider ROS mediators of a physiological cellular response
Following classical studies on messengers such as neurotransmitters (McLennan, 1963) and the most recent article by Lander (1997) on ROS in signal transduction, it is possible to put forward a set of criteria as requirements to consider ROS as true second messengers with the capacity to control cellular functions under physiological conditions. A first criterion should be that the putative ROS molecule acting as messenger or mediator of the hypoxic response must increase or decrease during hypoxia; a given relationship (modulation can modify that putative relationship) should exist between the ROS level change, the intensity of hypoxia and the strength of the hypoxic response. The second criterion would be that the cellular mechanism responsible for the change in the level of ROS molecule, putative messenger, needs to be identified. The third criterion would be the definition of the primary target of the ROS as well as the definition of the change produced by the ROS molecule on its target. The possibility exists that the primary target of the putative messenger ROS molecule is itself the effector(s) of the cell response or on the contrary, it is possible that the primary target of ROS is a first link of a chain or cascade of events coupling the change in the ROS levels to the effector(s) of the cell response; in this latter case the entire cascade should be defined. The fourth criterion would be to define the cellular responses elicited by the effector(s). The fifth criterion would be the definition of mechanisms responsible for the inactivation of ROS signal. Obviously if the ROS species increase during hypoxia we should be looking for ROS degrading mechanisms, but if they decrease we should be looking for the enzyme or cells process leading to the restoration of normal ROS levels. In any case, if a given stimulus acts via a change in ROS levels, the mechanisms for the elimination of those ROS should be induced by prolonged presentation of the stimulus. The sixth criterion (pharmacological) would be that the manipulation of the ROS levels, whether by reagents that modulate glutathione levels or that directly scavenge ROS, should alter the cell response in a predictable and reproducible manner; a sixth b or seventh criterion would be that overexpression or silencing of the expression of the ROS scavenging enzymes should alter the cell response in a predictable and reproducible manner.
First criterion: the signal ROS le6els during hypoxia
The very first question that should be addressed is if hypoxia increases or decreases ROS in general or if there is a unique ROS species whose production follows a particular behavior during hypoxia. The classical view is that the rate of production of ROS changes in direct relation to the tissue P O 2 (Chance et al., 1979; Archer et al., 1986 Archer et al., , 1989 . In fact, this view is generally accepted at present (Archer et al., 1993; Gorlach et al., 1994; Fandrey et al., 1994 Fandrey et al., , 1997 Halliwell and Gutteridge, 1999; Kietzmann et al., 2000; Gnaiger et al., 2000) . However, quite recently Schumacker and coworkers Duranteau et al., 1998; have found the opposite: hypoxia produces an increase in the cellular rate of ROS production which takes place at the level of mitochondria and which is proportional to the level of hypoxia. Chandel et al. (1998) claim that their measurements using dichlorofluorescein fluorescence, which apparently measures preferentially H 2 O 2 , are the correct ones. However there are many measurements using different methods (see Chance et al., 1979) in which it has been shown that hypoxia decreases the rate of production of ROS, the decrease being attributed to a decrease of production in mitochondria as well as in microsomal and peroxisomal enzymes. Archer et al. (1993) and Paky et al. (1993) using lucigenin chemiluminescence, which apparently measures preferentially O 2 − (Halliwell and Gutteridge, 1999) , also found that hypoxia decreases ROS production rate. Similarly contradictory are the observations regarding to CoCl 2 (an inducer of EPO production), which decreases the production of ROS if they are measured with dihydrorhodamine 123 , or increases their production if ROS are measured with dichlorofluorescein . Interestingly, both dyes yielded an inhibition of ROS generation under rotenone and diphenileneiodonium (DPI) (Cross et al., 1990; Ehleben et al., 1997; Chandel et al., 1998; Duranteau et al., 1998) ; rotenone and DPI also decreased lucigenin chemiluminescence (Archer et al., 1993 (Archer et al., , 1999 . However, while antimycin A increased dichlorofluorescein fluorescence it decreased lucigenin chemiluminescence (Archer et al., 1993) .
With this panorama it is difficult to make a meaningful formulation of the putative ROS molecule(s), which are signals for the hypoxic transduction cascade. We do not know if the signal should be a particular ROS species that decreases during hypoxia, a general decrease in the ROS levels, or if on the contrary, we should be searching for something that increases during hypoxia. We would like to quote (Semenza, 1999 (Semenza, , 2000 when he writes that 'the direct measurements of ROS are so demanding that they generate data supporting opposing views'. However, we want to make explicit some thoughts on the problem, being aware that experimental data might contradict the opinions expressed here. When we consider the general mechanisms for ROS production presented in previous paragraphs, the intuitive notion would be that the rate of production of ROS in cells should be directly proportional to the P O 2 of the cells. Reactions of auto-oxidation as well as oxidations driven by enzymes and the acceptance by molecular O 2 of electrons leaking at the level of the quinone pool in mitochondria (see Fig. 2 ) would decrease during hypoxia, when P O 2 is diminished. At the same time, however, it would appear that the generation of O 2 − at the quinone pool level would depend on the rate of flow of electrons through the respiratory chain, i.e. on the respiratory rate. As stated in the first section of this article, cell systems involved in the general homeostasis of O 2 are activated by hypoxia, this activation requiring an increase in cell respiration to support cell and homeostatic loop function (Obeso et al., 1993 (Obeso et al., , 1997 . Thus, it could be expected that in these specialized cells hypoxia produces an increase in electron flow during an ample range of hypoxia (from : 70 to 20 mmHg of arterial P O 2 ), and thereby, an increase in the electron leakage and mitochondrial formation of O 2 − is conceivable in those situations (see Fig. 3 in Hoshi and Heinemann, 2001 ) when hypoxia is intense enough a compromise will occur and in spite of the high affinity of cytochrome oxidase for O 2 , it will be unable to transfer enough electrons to O 2 and the respiratory rate and the genesis of ATP will drop. In the case of the CB in vivo this metabolic compromise occurs at arterial P O 2 : 20 mmHg; below this P O 2 the CB is unable to adequately signal the level of hypoxia and chemoreceptor action potential frequency decreases, instead of increasing (see Fidone and Gonzalez, 1996) . The majority of the cells of the organism will behave during hypoxia as the CB below the compromise P O 2 : all O 2 − -generating processes including that of mitochondria would decrease as the intensity of hypoxia increases. To state this in a different manner, it would appear that a differential response could be expected: in most cells of the organism hypoxia would tend to decrease ROS production while in CB chemoreceptor cells, in EPO-producing cells and in smooth muscle cells of the pulmonary arteries hypoxia would tend to increase ROS production at least in those ranges of hypoxia compatible with life. In contrast, Schumacker and co-workers measured an increase in ROS production in cardiomyocytes and hepatoma cells (EPO-producing) which is comparable in magnitude and in P O 2 dependence in both cell types Duranteau et al., 1998) and Fandrey et al. (1994) measured a decrease in the rate of production and release of H 2 O 2 to the incubating solution by EPO-producing hepatoma cells precisely in the range of P O 2 where they secrete EPO.
In sum, the first criterion is not settled, we do not know whether hypoxia increases or decreases ROS levels.
Second criterion: cell mechanisms responsible for the change in ROS production during hypoxia should be defined
Those proposing that hypoxia would decrease ROS levels (Cross et al., 1990; Youngson et al., 1993; Acker, 1994a,b; Acker and Xue, 1995; Fan-drey et al., 1994; Kietzmann et al., 2000; Weir and Archer 1995; Archer et al., 1993 Archer et al., , 2000 Fu et al., 2000) have been considering that a NADPH oxidase similar or identical to that present in phagocyte cells would be responsible for that decrease. The main findings to propose NADPH oxidase as the mechanism for the decrease in ROS production during hypoxia were: (1) the microspectrophotometric description in the CB of a cytochrome bgss, (2) the microspectrophotometric observation that hypoxic activation of the CB was paralleled by a reduction of FAD and NADP + and (3) the observation that DPI (an inhibitor of NADPH oxidase, and in general of all flovoenzymes) was able to activate the CB chemoreceptors' sensory discharge and to occlude the response to hypoxia. At the same time, DPI completely eliminated the fluorescent signal emitted by rhodamine 123 attributed to H 2 O 2 (Cross et al., 1990) . These initial observations were soon followed by the immunocytochemical demonstration of all the subunits of NADPH oxidase in the CB (Kummer and Acker, 1995) , although more recent studies have shown that most of the intraglomic immunostaining is localized in macrophages infiltrating the CB tissue (Dvorakova et al., 2000) .
As discussed elsewhere (Gonzalez, 1998) , this oxidase has a Km for O 2 (5 -30 mm or 3-18 mmHg) that would make reasonable the proposition that at the arterial P O 2 threshold for the activation of the homeostatic loops the rate of O 2 − formation by NADPH oxidase could start falling below Vmax. There are, however, several observations and considerations that in our opinion make untenable the proposal that the decrease in the activity of NADPH oxidase, and thereby the decrease in ROS generated by it, are the mediators or messengers linking the decrease of P O 2 to the cellular effectors. For example, NADPH is a multimeric enzyme with two membrane-bound and several cytoplasmic subunits, and to become active they need to be assembled in the membrane (Dang et al., 2001 ). The question therefore arises: what is the mechanism promoting the assembling of the subunits and of keeping the enzyme permanently active in resting normoxic conditions? Also, does the proposed hypoxic inhibition imply disassembling of the enzyme? Taking into account that K + channels are early effectors (may be the first effectors) of the hypoxic transduction cascade in chemoreceptor cells and in PASMC, and that they respond to low P O 2 in isolated membrane patches of rabbit and rat chemoreceptor cells (Ganfornina and Ló pezBarneo, 1991; Riesco et al., 2001) , how can we explain any activity and any back and forth change in activity of the enzyme in the inside-out patches perfused with saline at different P O 2 ? In addition, NADPH oxidase does not react with CO (Gabig et al., 1982; Iizuka et al., 1985 ) and yet CO, at concentrations just enough to compensate the decrease in P O 2 , is capable of preventing the inhibition of the K + channels produced by hypoxia (Ló pez-Ló pez and , the hypoxic activation of chemoreceptor activity (Lahiri et al., 1993) and the hypoxic vasoconstriction of the lung circulation (Tamayo et al., 1997) , implying that the cell system where O 2 is sensed has an affinity for CO comparable to that for O 2 itself (Fig. 4) .
Returning to the observations supporting NADPH oxidase involvement in O 2 sensing, it should be mentioned that recent studies have shown that, as predicted by the hypothesis, DPI does activate chemoreceptor cells promoting release of catecholamines in intact rat and rabbit CB; however, it does not occlude the response to hypoxia in either species (Obeso et al., 1999 (Obeso et al., , 2000a . In the same studies, two additional inhibitors of the oxidase did not modify the release of catecholamines in normoxic or in hypoxic conditions suggesting that DPI activation of chemoreceptor cells was not related to its ability to inhibit NADPH oxidase. In this regard, it should be mentioned that the effect of DPI on sensory discharges at concentrations capable of fully inhibiting the oxidase (Cross et al., 1990 ; see above) was much smaller than the response to a moderately intense hypoxic stimulus and, in addition, DPI produced irreversible damage to the CB-carotid sinus nerve preparation suggesting that the action of DPI was not related to the action of hypoxia. Even more recently, it has been shown that chemoreceptor cells from mice null for the neutrophil NADPH oxidase (for the 91 kDa Fig. 4 . Effects of CO on responses elicited by hypoxia. In (A) (redrawn with data from Ló pez-Ló pez and it can be seen that the inhibition of the K + currents produced by hypoxia (H, 5% O 2 equilibrated solutions vs. C, 20% O 2 in control conditions) was reversed by :75% in the presence of CO (H +CO; 5% O 2 +10% CO equilibrated solutions). In (B) the increase in the carotid sinus nerve activity elicited by hypoxia (P O 2 = 50 vs. 550 torr in control) was inhibited by about 70% by CO (O 2 =50 torr +CO= 140 torr) (calculated and drawn with data from Lahiri et al., 1993) . In (C) the increase in pulmonary arterial pressure elicited by hypoxia (blood P O 2 : 23 vs. 140 mmHg in control conditions) was reversed by nearly 90% in the presence of CO (blood P O 2 :23 mmHg and PCO:56 mmHg) (redrawn with data from Tamayo et al., 1997) . membrane bound subunit) exhibit a normal response to hypoxia measured as Ca 2 + transients in chemoreceptor cells or as ventilatory response (Roy et al., 2000) .
The situation in the pulmonary circulation is comparable. NADPH oxidase is present in PASMC and its inhibition with DPI fully blocked the hypoxic vasoconstriction (Thomas et al., 1991; Grimminger et al., 1995; Thompson et al., 1998) and decreased lucigenin chemoluminiscence (Archer et al., 1999) . Contrary to the hypothesis that hypoxia inhibits NADPH oxidase (see Weir and Archer, 1995) , these findings are compatible with the opposite notion, i.e. NADPH oxidase, if involved at all on hypoxic vasoconstriction, should be activated by hypoxia (and not inhibited) so that its inhibition by DPI abolishes the vasoconstrictor response. Consistent with this idea, Marshall et al. (1996) observed that hypoxia does indeed increase the activity of NADPH oxidase. However, NADPH oxidase does not appear to be involved at all on the genesis of hypoxic pulmonary vasoconstriction, because knock out animals for the neutrophil oxidase exhibited a normal hypoxic pulmonary vasoconstriction (Archer et al., 1999 (Archer et al., , 2000 . Even further, the data of Archer et al. (1993 Archer et al. ( , 1999 Archer et al. ( , 2000 appear to exclude ROS as mediators of the hypoxic pulmonary vasoconstriction. Thus, DPI and rotenone decreased lucigenin chemoluminiscence and, as just stated, DPI inhibits the hypoxic vasoconstriction, but rotenone per se produced a vasoconstrictor response, which was greater in null animals for NADPH oxidase. Both agents, DPI and rotenone, would inhibit complex I at mitochondrial level and reduce ROS production, and rotenone produces pulmonary vasoconstriction while DPI suppresses it. To further complicate the interpretations it has been found that in isolated PASMC DPI per se increased Ca 2 + i and elicited a contractile response in an ample range of concentrations, and in myocytes contracted by hypoxia DPI at 1 -5 mm inhibited the contraction but did not reduce the Ca 2 + i (Zhang et al., 1997) , indicating that DPI has side-effects down in the transduction cascade probably unrelated to NADPH oxidase inhibition (as appears to be the case in the CB, see above). Previously, it had been shown that DPI per se inhibited K + and Ca 2 + currents in a non-specific manner in PASMC and carotid body chemoreceptor cells .
Regarding EPO-producing cells (Gorlach et al., 1993; see Acker, 1994b) found microspectrophotometrical evidence of the presence of NADPH oxidase in hepatoma EPO-producing cells, and in western blot analysis they showed the presence in those cells of two of the subunits of the enzyme. Their proposal was identical to that described above for the CB chemoreceptor cells: hypoxia would decrease the activity of the enzyme and ROS levels would decrease, this decrease being a critical link between low P O 2 and the transcription of the EPO gene. However, Gleadle et al. (1995) showed that DPI per se applied in a range of concentrations from 0.3 to 5 mM did not activate EPO production in normoxic hepatoma cells; on the contrary, DPI inhibited in a dose-dependent manner hypoxia-induced, but not CoCl 2 -induced, EPO transcription. Obviously these findings argue against a role of NADPH oxidase inhibition in the genesis of the hypoxic response, otherwise DPI in normoxic conditions should mimic hypoxia and in hypoxic conditions should be ineffective or potentiate the effect of hypoxia. Regarding the lack of effect of DPI on CoCl 2 -induced EPO transcription the interpretation is difficult because as already stated CoCb decreases ROS production according to Fandrey et al. (1997) and increases the production according to Chandel et al. (1998) . The latter authors found that the production of ROS induced by CoCl 2 is of unknown, but extramitochondrial origin, and in any case insensitive to DPI. Finally, the participation of NADPH was questioned by Ratcliffe et al. (1995) arguing that EPO deficiency was not a trait in granulomatous patients which lack one or other subunit of NADPH oxidase and therefore the functional enzyme, and in fact, it was demonstrated by Wenger et al. (1996) that B-cell lines derived from normal and from granulomatous patients expressed vascular endothelial growth factor under hypoxic conditions and under CoCl 2 treatment in a very similar manner (the upregulation of vascular endothelial growth factor and EPO genes expression is considered to be under similar control); even further, reconstitution of the NADPH oxidase activity in granulomatous cells by transfecting the absent genes did not alter the sensitivity to hypoxia suggesting that H 2 O 2 levels are not critical to control the HIF-1a-dependent expression of vascular endothelial growth factor.
However, in keeping with the NADPH model, Fandrey et al. (1997) reported that desferrioxamine (an iron chelator which also increases EPO gene expression) and CoCl 2 decreased the production of ROS (as determined by dihydrorhodamine 123 fluorescence) as hypoxia does, therefore, they proposed that this diminution of ROS was the common factor for the three situations to increase EPO production. Even further, Fandrey et al. (1994) have previously found that addition of H 2 O 2 to the incubation medium (at concentrations greater than 100 mM) reduced or abolished the production of EPO induced by hypoxia, and in the 1997 article they reported that desferrioxamine antagonized the action of H 2 O 2 concluding that H 2 O 2 acted via OH generated by a Fenton reaction. These and other observations are in the most recent formulation of the model linking NADPH oxidase and hypoxic activation of gene expression. In this model the inhibition of the oxidase in hypoxia leads to a decrease in H 2 O 2 and as a consequence to a decrease in OH in perinuclear areas of the cell which ultimately would cause a change from oxidized to reduced state of the transcription factors triggering the transcription of hypoxia regulated genes (Kietzmann et al., 2000) . As already stated, it is hard for us to imagine a localized production of OH . Overall, however, this notion of a diminished rate of ROS production during hypoxia would fit the observations of Huang et al. (1996) who showed that hypoxia inducible factor-1a (HIF-1a; this factor would be the primary target or the primary effector of hypoxia in EPO-producing cells; see Fig. 1 ) which in normoxic conditions is degraded in the proteosome, is stabilized during hypoxia by a reduction process which allows it to reach the nucleus and to bind to the EPO gene enhancer to activate the rate of transcription. In fact Huang et al. (1996) reported that pre-exposure of hepatoma cells to H 2 O 2 prevented hypoxia induced HIF-1a protein accumulation, and additionally several back and forth putative manipulations of the HIF-la redox state with sulfhydryl reagents agreed with the overall notion that hypoxia stabilized HIF-1a by facilitating its reduced form via a decrease in ROS production.
As a result of all these difficult data, the trend in 2000 was that NADPH oxidase was not related to O 2 -sensing. Critical pieces to this thinking were the experiments in granulomatous patients and the experiments with knock out animals described above. However, new players are to be included in this venue. In neuroepithelial bodies (airway (Youngson et al., 1993; Fu et al., 1999) and the response to hypoxia of the cells is lost in knock outs for NADPH oxidase (Fu et al., 2000) . These finding would suggest that NADPH oxidase is linked to O 2 -sensing in these cells. Moreover, very recently several isoforms of NADPH oxidase have been cloned (e.g. Zhu et al., 1999; Geiszt et al., 2000) one of them named renox with a location in the renal cortex compatible with a possible function in the control of EPO-gene (Geiszt et al., 2000) .
The proponents of the theory that ROS increase during hypoxia Duranteau et al., 1998; Schumacker, 1999, 2000) state that it takes place at the level of mitochondria (Fig. 2) . Superoxide itself or H 2 O 2 (product of O 2 − dismutation) would reach the cytosol to stabilize HIF-la by promoting its oxidized form ; just the opposite to the claim given by Huang et al., 1996 ; see above). We have already speculated that in cells involved in homeostatic loops we should probably expect an increase in the production of ROS due to increased flow of electrons in the respiratory chain. Schumacker and co-workers propose that the increase in ROS they found would be due to a certain degree to the reduced state of the entire respiratory chain produced by the inadequate functioning of cytochrome oxidase imposed by hypoxia; this extra reduced state of the entire respiratory chain (in comparison to normoxia) would favor the reduced state of quinones and the leakage of electrons to form O 2 − . We would tend to believe that in cells involved in oxygen homeostatic loops this would occur at more extreme hypoxias due to the high affinity of cytochrome oxidase on the one hand (see Gnaiger et al., 2000) and due to the high blood flow of the organs wherein reside the cells forming part of the O 2 homeostatic loops, on the other.
A different question is whether increased ROS levels could be unequivocally considered mediators of the hypoxic responses. The answer is no (Table 1) . Thus, hypoxia, antimycin A and azide (and therefore cyanide) increase ROS levels (Duranteau et al., 1998) and only hypoxia increases the rate of transcription of EPO gene Pugh et al., 1991; Firth et al., 1994) . Rotenone and DPI, which decrease the levels of ROS, inhibit the hypoxic increase in EPO-gene transcription, but cyanide and antimycin A did not. In conjunction these data indicate that ROS levels per se are not related to EPO gene transcription, and that the energy metabolism of the cells is similarly unrelated to EPO gene transcription (during hypoxia, the three poisons, rotenone, cyanide and antimycin A should dramatically decrease ATP/ADP + AMP + Pi quotients and only rotenone inhibits the hypoxic response). In the case of the CB, all metabolic poisons including rotenone and amytal (acting at complex I), antimycin A (acting at complex III) and cyanide and azide (acting at complex IV; see Fig. 2 ) stimulate the CB chemoreception (Anichkov and Belen'kii, 1963; Joels and Neil, 1968; Mulligan and Lahiri, 1982; Matsumoto et al., 1987; Obeso et al., 1989a; Duchen and Biscoe, 1992) , and yet, rotenone and amytal decrease ROS levels while the rest of the inhibitors increase them. In the pulmonary circulation, the situation is comparable: hypoxia, rotenone and antimycin A which decreased lucigenin chemiluminescence increased pulmonary artery pressure and cyanide which increased chemiluminescence also increased pulmonary arterial pressure (Archer et al., 1993) ; obviously, according to Chandel and coworkers only rotenone should produce a decrease in ROS the rest of the situations would increase them, and yet all experimental maneuvers increased pulmonary artery pressure.
Third criterion. The primary target for the increased or decreased le6els of ROS should be identified. The change produced in the target by the signal (change in ROS le6els) should be defined. The mechanisms of target/effector coupling should also be defined
We do not know the identity of the primary ROS targets in the hypoxic transduction cascade. Therefore, we will equate the primary target of ROS with the first known or suspected effector on the cells which are K + channels in the case of CB chemoreceptor and PASMC and HIF-1a in the case of EPO-producing cells (see Fig. 1 ). The recognition that release of catecholamines induced by hypoxia in the CB chemoreceptor cells, as well as that induced by high extracellular K + , was inhibited by dihydropyridine antagonists of L-type Ca 2 + channels (Obeso, 1984) suggested to us that hypoxia must depolarize chemoreceptor cells. This observation prompted us to develop a primary culture of rabbit CB dissociated cells to study electrophysiologically chemoreceptor cells. In agreement with previous data of our laboratory (Obeso, 1984; Almaraz et al., 1986; Rocher et al., 1988) . Following this initial finding, the presence of O 2 -modulated K + currents in chemoreceptor cells has been recognized in all the species studied. In the rat chemoreceptor cells two types of O 2 -modulated K + channels have been described; a Ca 2 + -dependent K + current (Peers, 1990) carried out by the maxi-K + (Wyatt and Peers, 1995; Ló pez-Ló pez et al., 1997 ) and a leak voltage-independent current (Buckler, 1997 (Buckler, , 1999 , recently identified as TASK-1 channel (Buckler et al., 2000) . In the cat CB chemoreceptor cells, K + current sensitive to hypoxia is a delayed rectifier-like current (Chou and Shirahata 1996) . In PASMC, the original description of Demodulated KT channels was made on freshly dispersed canine fibers, and it was found that the KT current sensitive to hypoxia was Ca 2 + -dependent (Post et al., 1992) . Soon after, Yuan et al. (1993) found that in primary cultures of rat PASMC the current sensitive to hypoxia was of the Ca 2 + independent delayed rectifier type (Yuan et al., 1993) . In more recent studies (e.g. Yuan et al. 1998; Archer et al., 1998; Patel et al., 1997; Osipenko et al., 2000) several Kv channels have been identified in PASMC and it would appear that those channels most likely to carry the O 2 -sensitive current would be the homomeric Kv1.2, Kv1.5, the Kv2.1, the Kv3.1 and the heteromeric Kv1.2/Kv1.5 and Kv2.1/Kv9.3 (see Pérez-García and Ló pez-Ló pez, 2000; Archer et al., 2000) .
In accord with criterion 3, experimental findings must clarify to what extent, if any, the O 2 modulated channels are sensitive to redox changes, and if so, to determine if those redox changes are likely to be produced by hypoxia. Fast inactivating channels supporting macroscopic currents like those sensitive to hypoxia in rabbit chemoreceptor cells are susceptible to modulation by redox agents including H 2 O 2 , dithiothreitol, dithiodipyridine, GSH and GSSG (Ruppersberg et al., 1991; Vega-Saenz de Miera and Rudy, 1992; Ló pez-Barneo et al., 1999; Pérez-García et al., 1999) , and in general, the modulation occurs in an adequate manner (taking as valid the assumption that hypoxia decreases ROS levels), i.e. reducing agents decrease the opening probability of the channels or the amplitude of the currents and oxidizing agents do the opposite. However, the opening probability of O 2 -sensitive K + channels decreases in isolated patches on lowering P O 2 (Ganfornina and Ló pez-Barneo, 1991; Pérez-García et al., 1999) in a reversible manner, and to our knowledge, O 2 at the ranges of pressures we are dealing with (10-150 mmHg), cannot oxidize or reduce thiol or other functional groups in the proteins (except for some autoxidation of tyrosine and tryptophan; Halliwell and Gutteridge, 1999) . In addition, it is necessary to postulate that a redox system capable of transferring the electrons back and forth to the channel protein is present in the isolated membrane patches (see the above comments on the article by Eu et al., 2000) . Furthermore, CO is able to prevent or to reverse the action of hypoxia on K + currents (i.e. CO behaves as O 2 ; Ló pez-Ló pez and ) and yet there are no cell mechanisms by which the highly unreactive CO at the concentrations used can substitute O 2 to increase the rate of ROS production. Maxi-K + channels, which are O 2 -modulated in rat chemoreceptor cells, are also sensitive to modulation by redox reagents like those mentioned above for the transient K + channels, but the direction of those modulations are not always the expected ones (Thuringer and Findlay, 1997; Liu et al., 1999; Soh et al., 2001; Riesco et al., 2001 ; but see Tang et al., 2001) . Therefore, the notion of hypoxia acting through reduction of sulfhydryl or other chemical groups of the channel proteins susceptible to redox modulation seems untenable, especially if we consider that CO is able to reverse the effect of hypoxia in isolated membrane patches of rat chemoreceptor cells increasing the opening probability of maxi-K + when it is decreased by hypoxia (Riesco et al., 2001) . In this regard, it should be mentioned that in a recent study from our laboratory it was possible to clearly distinguish between the action of reducing agents and the action of low P O 2 : we observed that dithiothreitol was able to modify some kinetic properties of transfected shaker and shaker/b1.2 and Kv4.2/b1.2 channels, while low P O 2 only modulated the latter channels (Pérez-García et al., 1999) . In other words, it is possible that reducing agents alter the conducting properties of ion channels, but that does not necessarily mean that hypoxia alters those properties, and if hypoxia alters them, it may be that the direction of the alteration could be different. The same type of arguments can be made regarding the regulation of K + channels by redox agents versus hypoxic regulation in PASMC: in general the modification of the currents by reducing agents corresponds to that of hypoxia (see Archer et al., 2000) but the sensitivity to hypoxia of Kv3.1 in isolated patches (Osipenko et al., 2000) 1 brings the same considerations just mentioned in the case of the CB chemoreceptor cells.
The identification of HIF-1a as the primary effector in EPO producing cells occurred as a result of coordinated studies of several groups. Transgenic mice carrying a 4 kb fragment of the human erythropoietin gene which contained the 5 exons and 4 introns of the intact gene, a 0.4 kb of the 5% end and a 0.7 kb of the 3% end exhibited hypoxic induction of the human gene as bleeding resulted in increased levels of human EPO mRNA in the liver of the mice; in addition, several transgenic mice derived from different independent cell lines were polycythemic (see Semenza 1994) . The findings indicated that the EPO-gene fragment contained hypoxia regulated elements. The description by Golberg and co-workers of two human hepatoma cell lines exhibiting hypoxia regulated expression of EPO (Goldberg et al., 1987 (Goldberg et al., , 1988 allowed an ample series of trasfection experiments with reporter genes which fed to the discovery of the 3' enhancer region with the ability to bind proteins (e.g. Pugh et al., 1991) . A search aimed at identifying the protein factors binding to the 3% enhancer culminated with the 1 In our whole-cell patch recordings, CO was used by gas bubbling of the perfusing solutions. The gas mixtures contained: 20% O 2 /80% N 2 , in control conditions; 5% O 2 /95% N 2 , in hypoxic conditions, and; 5% O 2 /10% CO/85% N 2 , during CO application. This concentration of CO prevented or reversed the effect of 5% O 2 by :70%. With this O 2 /CO ratio, cytochrome oxidase should not be inhibited and therefore ROS production of mitochondrial origin would not increase; it is possible that some other enzymatic system with the potential to generate ROS (e.g. cytochrome P450 oxidases) could be inhibited, and therefore, it is possible that ROS could have decreased (Coburn R.F. and Forman H. J. Carbon monoxide toxicity. In A.P. Fishman, ed. The Respiratory System IV. American Physiological Society, Bethesda, MD, pp 439 -56, 1987) . identification of HIF-1 (Wang and Semenza, 1993a,b) as a factor induced by hypoxia, capable of binding to the 3' enhancer region of EPO and other hypoxia-regulated genes and capable of causing an increase in their rate of transcription. Thereafter, it was demonstrated that in fact HIF-1 was a heterodimer composed of HIF-1a, whose levels are regulated by low P O 2 , and by the constitutively expressed HIF-1b [also known as ARNT (aryl hydrocarbon receptor nuclear translocator), as AhR (aryl hydrocarbon receptor) and as dioxin receptor], the dimerization was shown to be necessary, not for the translocation of both components to the nucleus, but for the stable association of HIF-1 within the nuclear compartment (see Gassmann et al., 2000) . Additional studies demonstrated that HIF-1a as well as HIF-1b mRNA levels, transcription and translation rates were not modified by hypoxia. Since HIF-1a protein increased during hypoxia it implied that in normoxia the protein is degraded and that hypoxia prevents the degradation (Huang et al., 1996) .
Therefore, the question we should make at this point is how the change in ROS levels produces such stabilization of HIF-1a to prevent its degradation. Huang et al. (1996) showed that the levels of HIF-1a, which are increased by hypoxia, decreased soon if intact cells were re-exposed to normoxia (21% O 2 ), but exposure of cell extracts to the same normoxic levels of O 2 did not alter the binding of HIF-1a to DNA. In other words, for high P O 2 to destabilize HIF-1a the integrity of the cells is necessary. In additional experiments it was shown that H 2 O 2 (0.1 -1.0 mM) resulted in a dose-dependent decrease in the EPO mRNA expression induced by hypoxia which runs parallel to a decrease in HIF-1a binding to DNA and to a decrease in HIF-1a protein, without modification of HIF-1a mRNA levels or translation rate. It was also observed that extracts from hypoxic cells treated with H 2 O 2 showed a normally high binding capacity to DNA. Those findings appear to indicate that the binding of HIF-1a to DNA is controlled primarily at the level of HIF-1a protein. In addition, Huang et al. (1996) also studied some of the modifications of HIF-1a which might alter its binding to DNA. They found that oxidizing sulfhydryl reagents added to cell extracts inhibited the binding in a dose-dependent manner, this inhibition was reversible with reducing thiol reagents except when sulfhydryl alkylating agents were used. In addition, in a cotransfection experiment using a construct expressing thioredoxin under the control of the constitutive cytomegaloviral promoter and enhancer, along with another construct expressing luciferase under the control of the SV40 promoter and EPO-enhancer, they observed that overexpression of thioredoxin resulted in a potentiation of the expression of luciferase both in normoxic and hypoxic conditions, such potentiation appeared to be under the control of the HIF-1 binding because transfection with a mutated EPO enhancer, which was unable to bind HIF-1a, caused the loss of the response. As a whole the results would indicate that H 2 O 2 , like normoxia, produces modifications in the HIF-1a molecule which force it to be directed to degradation, but which does not impede its binding to DNA. Alternatively, hypoxia promotes changes in HIF-1a, which prevent its degradation, leading to accumulation of the transcription factor; the changes induced by hypoxia appear to be redox dependent because they can be mimicked by thioredoxin and counteracted by normoxia and H 2 O 2 ; a similar conclusion was attained by Srinivas et al. (1999) . An alternative interpretation to the findings of Huang et al., is that hypoxia (or the decrease of ROS) or the overexpression of thioredoxin produced changes in the degrading enzymes of the proteosoma which make them incapable of degrading a normal (or reduced) HIF 1a.
However, in a series of experiments found essentially the opposite: hypoxia and CoCl 2 , but not desferriexamine, increased ROS levels, and the three situations augmented the expression of a reporter gene under the control of the EPO-promoter as well as the amount of HIF-1a protein. Inhibitors of the respiratory chain at the complex I, the thiol reductant pirrolidine dithiocarbamate, and overexpression of catalase, decreased hypoxic ROS levels and prevented the augmented expression of HIF-1a. The thiol reductant and the overexpression of catalase decreased the ROS levels increased by CoCl 2 and also the expression of HIF-1a. Neither maneuver decreased the expression of the reporter gene or decreased the levels of HIF-1a promoted by desferrioxamine. Addition of H 2 O 2 and tert-butylhydroperoxide to normoxic cells promoted an increase of HIF-la protein as well as an increased expression of the reporter gene; these maneuvers were ineffective in cells overexpressing catalase. A phosphatase inhibitor and an inhibitor of phosphatidyl inositol 3-kinase abolished the stabilization of HIF-1a induced by hypoxia, CoCl 2 and desferrioxamine and a proteasome inhibitor was able to reverse those effects; because treatment of the cells with H 2 O 2 was unable to prevent the effects of the phosphatase and kinase inhibitors, the authors concluded that ROS (including H 2 O 2 ) act to stabilize HIF-1a at a step prior to the action of the phosphatases and kinases. Desferrioxamine would produce the stabilization of HIF-1a by a mechanism independent of ROS and would also act at a step prior to the phosphatases and kinases. Curiously, antimycin A, which increased ROS, did not induce the expression of the reporter gene or accumulation of HIF-1a. state that it is because this mitochondrial inhibitor causes a smaller increase in ROS levels than hypoxia. However, it is difficult to understand how hypoxia can produce a more reduced state at the quinone pool than antimycin (see Fig. 2 ). In addition, antimycin A was applied in normoxia implying that the concentrations of O 2 to accept the electrons from semiquinone are much higher than in hypoxia (20% O 2 vs. 1.5% in their experiments) and, therefore, the formation of O 2 − should be facilitated (Chance et al., 1979) . The controversy is obvious: to Huang et al. (1996) it is the decrease of ROS levels which causes the stabilization of HIF-1a and to it is the increase of ROS levels that does the same. Therefore, and in keeping with the statement of the third criterion, we do not know if we should be looking for a reduction or an oxidation of HIF-1a as responsible for its stabilization. An additional aspect that we feel forced to restate at this point (which is seldom taken into account; see above) is that in the proposed signalling by ROS the subcellular localization of the ROS signal at the target place should be taken into consideration, otherwise a 'true' signaling would not exist, Finally, we agree with Halliwell and Gutteridge (2000) when they state regarding signaling by ROS: ''one must be wary: cells in culture are usually hyperoxic and they lack many of the antioxidants they use in vivo…Cells adapt to live in culture. It is not impossible that, with tumor cell lines in particular, adaptations to favor growth may occur by using radicals to trigger pathways that are triggered by other means in vivo''.
Fourth criterion. Definition of the cellular responses elicited by the effector acti6ated by the changes in ROS le6els
At this point in the article it is obvious that we can define the cellular responses elicited by the stimulus, i.e. hypoxia. However, we have serious difficulties in defining the cellular effects produced by the ROS level changes occurring during hypoxia because we do not know what those changes are. And even if we knew the changes in ROS levels produced during hypoxia we do not know if they are cause or consequence of activation of the effector and cellular responses.
Hypoxia in CB chemoreceptor cells and PASMC reduces the opening probability of the O 2 regulated K + channels (see criterion 3) leading to cell depolarization, activation of voltage operated Ca 2 + channels and release of neurotransmitters in chemoreceptor cells or contraction in smooth muscle cells (see Fig. 1 ). In criterion 3 we have already indicated that sulfhydryl reagents cause changes in the opening probability or amplitude of the currents that can be compatible with a decrease or an increase in ROS levels. Referring specifically to ROS, there are many studies in which H 2 O 2 has been applied directly and its effects on several types of K + channels established. For example, Vega-Saenz de Miera and Rudy (1992) (Wang et al., 1996; Fu et al., 2000) . And there are many reports showing that H 2 0 2 or tert-butylhydroper-oxide activate maxi-K + (Hayabuchi et al. 1998; Shin et al., 2000; Guo et al., 2000; Barlow et al., 2000) . All these data would favor the notion that hypoxia decreases ROS, and thereby hypoxia would decrease the activity of K + channels and depolarization would occur. However, there are studies in which it has been found that H 2 O 2 inhibits K + channels. That is the case for maxi-K + (DiChiara and Reinhart, 1997; Tang et al., 2001) . These studies would be in agreement with the notion that hypoxia increases ROS levels and thereby causes inhibition of K + channels, cell depolarization and increased cell activity.
When we consider the effects of H 2 O 2 on the overall response of the system, the study of Osanai et al. (1997) in the intact CB is very illustrative as they concluded that maneuvers aimed at altering endogenous H 2 O 2 , including exogenous H 2 O 2 application, did not provide evidence for its supposedly critical role in O 2 chemoreception. On the contrary, in the pulmonary circulation tertbutylhydroperoxide, H 2 O 2 and ROS generating systems (i.e. perfusion of the lungs with xanthine plus xanthine oxidase) clearly inhibited hypoxic pulmonary vasoconstriction (Archer et al., 1986; Mohazzab and Wolin, 2000) . In the case of EPOproducing cells we have commented in previous paragraphs on the apparently dual actions of H 2 O 2 since on the one hand it inhibited EPO-production induced by hypoxia and on the other hand it augmented the stabilization of HIF-1a and promoted the expression of a reporter gene under the control of the EPO enhancer . It should also be mentioned that Ueno et al. (1988) working with renal carcinoma EPO-producing cells and Ndele et al. (1996) ) working with HEP 3B cells found that H 2 O 2 and ROS generating systems increased EPO production while ROS scavengers have the opposite effects.
Fifth criterion. The mechanism(s) responsible for the inacti6ation of the ROS signal should be defined
Obviously we should consider here both possibilities: that the signal is a decrease and that the signal is an increase in ROS levels. In the first case, if a decrease in ROS levels is considered to be the result of a decrease in the activity of NADPH oxidase, the signal would disappear, i.e. normal ROS levels will be recovered, when P O 2 returns to normoxic levels due to an increase in the activity of the enzyme by increased levels of substrate (it might also require a reassembly of the NADPH subunits promoted by unknown mechanisms; see second criterion). It is conceivable that chronic hypoxia would produce a downregulation of NADPH oxidase. A comparable mechanism to inactivate the ROS signal would be valid whether the decrease of ROS levels is considered to occur at the mitochondrial level, cytochrome P450, etc. If on the contrary, the signal is an increase in ROS levels, a given level of ROS should correspond to a given level of stimulation in order to obtain a response proportional to the intensity of the stimulus. This would imply that simultaneously to the activation of the mechanisms generating ROS there is a parallel activation of the mechanisms degrading them. If the stimulation is long lasting (e.g. chronic hypoxia) an upregulation of the mechanisms degrading ROS should be expected (Halliwell and Gutteridge, 1999 ). Obviously we are referring here to GSH, glutathione peroxidase, catalase and superoxide dismutase as the main systems to dispose ROS. There are not, to our knowledge, direct measurements of those ROS scavenger systems in the cell types we are discussing, however, there are some fragmentary data obtained in intact animals and humans exposed to high altitude. For example, Costa et al. (1993) obtained evidence indicating that in the liver of rats exposed to a simulated altitude of 4400 m there was a decrease in the rate of ROS production with a concomitant decrease in superoxide dismutase activity. However, Nakanishi et al. (1995) at a simulated altitude of 5500 m found a complex pattern of changes in those enzymes which was organ specific, and which was accompanied by an increase in lipid peroxidation and by a marked decrease in body weight of the animals attributed to an increased metabolic rate due to the hypobaric stress. Although it is difficult from these and similar data to reach sound conclusions, some experts in the area would suggest that there are risks of oxidative stress, independent of UV radiation, at high altitude (Simon-Schnass, 2000 The interpretation of the data resulting from the manipulation of ROS and/or glutathione levels is not always straightforward due to the multiple targets of ROS. For example, the activation or mimicking of glutathione peroxidase (e.g. by administration of ebselen) would decrease the GSH/ GSSG ratio, just as a situation in which there is an increase in the rate of ROS production, but contrary to that situation ebselen will produce a decrease in the levels of H 2 O 2 . Since the decrease in the GSH/GSSG ratio would tend to increase the opening probability of K + channels, and thereby to cause membrane hyperpolarization (and vasodilation, in the case of pulmonary circulation), and the decrease of H 2 O 2 would tend to reduce the activity of guanylate cyclase, and thereby to inhibit Ca + dependent K + channels (and to produce vasoconstriction, in the case of pulmonary circulation), the overall effect could be very complex and difficult to define (see Wolin et al., 1999; Mohazzab and Wolin, 2000) . In addition, and at least in the case of the lung, ROS can modify the metabolism of arachidonic acidderived metabolism in such a manner that an increase in ROS levels would augment the production of vasoconstrictor metabolites (Seeger et al., 1986; Sanderud et al., 1993; see Wolin et al., 1999) .
Experiments in the CB directly focused on this last criterion have been performed in our laboratory very recently. We have measured GSH and GSSG levels in calf CB in normoxia, hypoxia and after treatment of the organs with N-acetylcysteine, a precursor of glutathione and direct scavenger of ROS and measured the release of catecholamines from chemoreceptor cells in those experimental situations (Obeso et al., 2000b) . Nacetylcysteine would mimic a situation in which there is a decreased production of ROS and would oppose a situation of increased rate of ROS production. In other words, N-acetylcysteine would mimic hypoxia, if we accept that hypoxia decreases ROS levels, and would oppose hypoxia if we accept that it augments ROS levels. We found that hypoxia (P O 2 : 46 mmHg) did not alter the absolute levels or the GSH/GSSG quotients. N-acetylcysteine increased absolute glutathione levels by primarily increasing GSH; therefore, it increased the GSH/GSSG ratio. Yet N-acetylcysteine did not modify the basal normoxic or hypoxia-induced release of catecholamines suggesting that ROS are not critical in setting the hypoxic response.
In the case of the pulmonary circulation, Archer et al. (1986) showed that diamide (an agent that reacts with GSH and oxidizes it to GSSG) reduced the pressor response to hypoxia. Diamide would mimic a situation in which there is an increased production of ROS: it will cause a decrease in GSH/GSSG ratio and therefore the cellular power for scavenging of ROS leading to an increase in ROS levels. Both the decrease in GSH/GSSG ratio and the increase in ROS levels would tend to oppose the vasoconstriction provoked by hypoxia (see above). In agreement with the expected actions, pretreatment of the animals with N-acetylcysteine prevented the effects of diamide (Archer et al., 1986) . In isolated perfused lungs, suplementation of the superfusates with catalase and superoxide dismutase neutralized the inhibition on hypoxic pulmonary vasoconstriction produced by ROS generating systems (xanthine/ xanthine oxidase) (Archer et al., 1986) . But in another article it was reported that neither catalase nor superoxide dismutase modified the vasoconstriction elicited by hypoxia (Kjaeve et al., 1990) , and more recently Weissmann et al. (1998) also found that superoxide dismutase was similarly ineffective. In this latter study several potential ROS scavengers were used and the results were inconclusive as from all the agents tested [superoxide dismutase, aminotriazole (a catalase inhibitor), tiron (a presumed superoxide scavenger) and nitro blue tetrazolium (another superoxide scavenger)] only nitro blue tetrazolium inhibited hypoxic pulmonary vasonstriction. In sum, the experiments aimed to alter ROS levels by manipulation of ROS scavenging systems in the lung have yielded conflicting results, and are therefore not conclusive with regard to the possible significance of ROS levels on hypoxic pulmonary vasoconstriction.
The data related to this criterion in EPO-producing cells are likewise inconclusive. In discussing the stabilization of HIF-1a (criterion 3) we have focused on some discrepancies that might relate to this criterion. For example, we have mentioned that according to Huang et al. (1996) overexpression of thioredoxin potentiated the expression of a reporter gene under the control of EPO enhancer implying stabilization of HIF-1a. On the other hand, reported that overexpression of catalase prevented stabilization of HIF-1a. A similar controversy exists regarding H 2 O 2 . Thus Fandrey et al. (1994) reported that H 2 O 2 inhibited the production of EPO induced by hypoxia and that catalase reversed the inhibition produced by H 2 O 2 . On the contrary, Ueno et al. (1988) , Ndele et al. (1996) (see also reported that catalase inhibited the EPO production stimulated by H 2 O 2 and by ROS-generating systems glucose/glucose oxidase and xanthine/xanthine oxidase.
Conclusion
With the available information we do not know if hypoxia increases or decreases ROS levels, and therefore we do not know if the putative role of ROS, i.e. to inhibit K + channels in the CB chemoreceptor cells and in PASMC and to stabilize HIF-1a in EPO-producing cells, is the result of the reduction or the oxidation of the K + channel proteins or HIF-1a. The uncertainties remain when we consider the effects of agents that increase or decrease ROS levels on the responses of CB chemoreceptor cells, PASMC and EPOproducing cells. There are several mitochondrial poisons, which have opposite effects on the rate of ROS production and levels, and yet all activate chemoreceptor cells and PASMC in normoxia and potentiate their hypoxic response. Similarly, there are mitochondrial agents that can either decrease or increase ROS levels, yet they fail to alter normoxic EPO production, implying that neither the decrease nor the increase in ROS levels mimic hypoxia. The panorama is not clarified by the use of agents or experimental maneuvers that alter the rate of ROS scavenging. There are reports indicating that ROS scavenging enzymes or drugs tend to mimic hypoxia and reports indicating the opposite, both, in PASMC and in EPOproducing cells. In the CB chemoreceptor cells the scavenging of ROS did not alter the normoxic output of the cells nor their hypoxic response. In sum, the available information on O 2 -sensing/hypoxic transduction does not support an unequivocal role for ROS in those cellular processes. The possibility exists that many of the contradictory findings, which have been obtained in tumor cell lines, represent peculiarities of particular clones used in different laboratories. In any case, it should always be kept in mind that the metabolic properties of tumor cells might differ substantially from the parental normal cells. In designing experiments, it should also be remembered that maneuvers aimed at manipulating ROS can do more than simply alter ROS levels: special care should be taken in selecting the potentially pleiotropic ROS scavengers and ROS mimetics.
